$0.8000
0.0081.01%
Últ. Act.: Oct 9, 9:56 AM
$0.7871
-0.0049-0.62%
Rani Therapeutics Hldgs (RANI) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.05 | $-0.05 | $-0.05 | $-0.11 |
| Actual | $-0.04 | $-0.04 | $-0.07 | $-0.12 |
| Surprise | +20.0% | +20.0% | -40.0% | -9.09% |
| Revenue | ||||
| Estimate | $1.1M | $500000 | $7.0M | $4.0M |
| Actual | $1.7M | $1.7M | $1.5M | $0 |
| Surprise | +58.1% | +241.6% | -79.1% | -100.0% |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.05 | $-0.05 |
| Revenue | ||
| Consensus | $1.4M | $1.6M |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 13, 2026 | $-0.04 | $-0.05 | 20.0 % |
| Q1 | May 15, 2026 | $-0.04 | $-0.05 | 20.0 % |
| Q4 | Mar 26, 2026 | $-0.07 | $-0.05 | -40.0 % |
| Q3 | Nov 6, 2025 | $-0.12 | $-0.11 | -9.09 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 13, 2026 | $1.71M | $1.08M | 58.1 % |
| Q1 | May 15, 2026 | $1.71M | $500.00K | 241.6 % |
| Q4 | Mar 26, 2026 | $1.46M | $7.00M | -79.1 % |
| Q3 | Nov 6, 2025 | $0 | $4.00M | -100.0 % |